Founded by the Cord Blood Center Group,CBC Health has pioneered advancements in regenerative health since 1997, processing cord blood for transplants and serving over 160,000 clients. Eurocord-Slovakia has been recognized for achieving the highest average quantity of total nucleated cells in cord blood grafts globally for eight consecutive years.
CBC Health offers umbilical cord blood cell intravenous infusion for ischemic stroke recovery, drawing on over 20 years of experience in cord blood banking and treatments with allogeneic cord blood.
Prof. Nils Thoennissen is an international specialist in cancer, chronic degenerative diseases, and regenerative medicine with over 20 years of experience in evidence-based medicine and 14 years of clinical experience in hemotherapy. He has authored 40 scientific publications in peer-reviewed journals and has been awarded 6 awards. He has received postgraduate training at the University of Münster, Cardiff University School of Medicine, University of Mainz, and Cedars-Sinai Medical Center. He currently holds the position of medical director of CBC Health, and has held previous positions as chief physician in St. George Hospital, Kloster Paradies Medical Center, and the University Medical Center Hamburg-Eppendorf.
Written by Mariia Mytrofankina
Written by Anna Leonova
Written by Mariia Mytrofankina
Written by Mariia Mytrofankina